Literature DB >> 27614227

Reduced mitochondrial respiration in the ischemic as well as in the remote nonischemic region in postmyocardial infarction remodeling.

Diogo T Galan1, Virginie Bito1, Piet Claus2, Patricia Holemans1, Joëlle Abi-Char1, Chandan K Nagaraju1, Eef Dries1, Kristel Vermeulen1, Renée Ventura-Clapier3, Karin R Sipido4, Ronald B Driesen1.   

Abstract

Scarring and remodeling of the left ventricle (LV) after myocardial infarction (MI) results in ischemic cardiomyopathy with reduced contractile function. Regional differences related to persisting ischemia may exist. We investigated the hypothesis that mitochondrial function and structure is altered in the myocardium adjacent to MI with reduced perfusion (MIadjacent) and less so in the remote, nonischemic myocardium (MIremote). We used a pig model of chronic coronary stenosis and MI (n = 13). Functional and perfusion MR imaging 6 wk after intervention showed reduced ejection fraction and increased global wall stress compared with sham-operated animals (Sham; n = 14). Regional strain in MIadjacent was reduced with reduced contractile reserve; in MIremote strain was also reduced but responsive to dobutamine and perfusion was normal compared with Sham. Capillary density was unchanged. Cardiac myocytes isolated from both regions had reduced basal and maximal oxygen consumption rate, as well as through complex I and II, but complex IV activity was unchanged. Reduced respiration was not associated with detectable reduction of mitochondrial density. There was no significant change in AMPK or glucose transporter expression levels, but glycogen content was significantly increased in both MIadjacent and MIremote Glycogen accumulation was predominantly perinuclear; mitochondria in this area were smaller but only in MIadjacent where also subsarcolemmal mitochondria were smaller. In conclusion, after MI reduction of mitochondrial respiration and glycogen accumulation occur in all LV regions suggesting that reduced perfusion does not lead to additional specific changes and that increased hemodynamic load is the major driver for changes in mitochondrial function.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  chronic ischemia; hemodynamic load; mitochondria; perfusion

Mesh:

Substances:

Year:  2016        PMID: 27614227     DOI: 10.1152/ajpheart.00945.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

1.  Inhibition of the ubiquitous calpains protects complex I activity and enables improved mitophagy in the heart following ischemia-reperfusion.

Authors:  Qun Chen; Jeremy Thompson; Ying Hu; Joseph Dean; Edward J Lesnefsky
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-14       Impact factor: 4.249

2.  A perfusable, multifunctional epicardial device improves cardiac function and tissue repair.

Authors:  Shixing Huang; Dong Lei; Qi Yang; Yang Yang; Chenyu Jiang; Hongpeng Shi; Bei Qian; Qiang Long; Wenyi Chen; Youming Chen; Lan Zhu; Wenjie Yang; Lan Wang; Wangxi Hai; Qiang Zhao; Zhengwei You; Xiaofeng Ye
Journal:  Nat Med       Date:  2021-03-15       Impact factor: 53.440

3.  Modulating mitochondrial dynamics attenuates cardiac ischemia-reperfusion injury in prediabetic rats.

Authors:  Chayodom Maneechote; Siripong Palee; Sasiwan Kerdphoo; Thidarat Jaiwongkam; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Acta Pharmacol Sin       Date:  2021-03-12       Impact factor: 6.150

4.  Hyperactive ryanodine receptors in human heart failure and ischaemic cardiomyopathy reside outside of couplons.

Authors:  Eef Dries; Demetrio J Santiago; Guillaume Gilbert; Ilse Lenaerts; Bert Vandenberk; Chandan K Nagaraju; Daniel M Johnson; Patricia Holemans; H Llewelyn Roderick; Niall Macquaide; Piet Claus; Karin R Sipido
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

5.  High intensity training improves cardiac function in healthy rats.

Authors:  Maxim Verboven; Anne Cuypers; Dorien Deluyker; Ivo Lambrichts; Bert O Eijnde; Dominique Hansen; Virginie Bito
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

6.  LncRNA LncHrt preserves cardiac metabolic homeostasis and heart function by modulating the LKB1-AMPK signaling pathway.

Authors:  Ning Liu; Masaharu Kataoka; Yingchao Wang; Linbin Pu; Xiaoxuan Dong; Xuyang Fu; Feng Zhang; Feng Gao; Tian Liang; Jianqiu Pei; Changchen Xiao; Qiongzi Qiu; Tingting Hong; Qiming Chen; Jing Zhao; Lianlian Zhu; Junhua He; Xiaoyun Hu; Yu Nie; Wei Zhu; Hong Yu; Douglas B Cowan; Xinyang Hu; Jian'an Wang; Da-Zhi Wang; Jinghai Chen
Journal:  Basic Res Cardiol       Date:  2021-08-11       Impact factor: 17.165

Review 7.  Ventricular Arrhythmias in Ischemic Cardiomyopathy-New Avenues for Mechanism-Guided Treatment.

Authors:  Matthew Amoni; Eef Dries; Sebastian Ingelaere; Dylan Vermoortele; H Llewelyn Roderick; Piet Claus; Rik Willems; Karin R Sipido
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

8.  Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction.

Authors:  Chandan K Nagaraju; Eef Dries; Natasa Popovic; Abhishek A Singh; Peter Haemers; H Llewelyn Roderick; Piet Claus; Karin R Sipido; Ronald B Driesen
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

9.  Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.

Authors:  Masashi Mizuno; Atsushi Kuno; Toshiyuki Yano; Takayuki Miki; Hiroto Oshima; Tatsuya Sato; Kei Nakata; Yukishige Kimura; Masaya Tanno; Tetsuji Miura
Journal:  Physiol Rep       Date:  2018-06

10.  Altered adrenergic response in myocytes bordering a chronic myocardial infarction underlies in vivo triggered activity and repolarization instability.

Authors:  Eef Dries; Matthew Amoni; Bert Vandenberk; Daniel M Johnson; Guillaume Gilbert; Chandan K Nagaraju; Rosa Doñate Puertas; Mouna Abdesselem; Demetrio J Santiago; H Llewelyn Roderick; Piet Claus; Rik Willems; Karin R Sipido
Journal:  J Physiol       Date:  2020-02-11       Impact factor: 5.182

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.